Cargando…

Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening

Orthopoxvirus species like cowpox, vaccinia and monkeypox virus cause zoonotic infections in humans worldwide. Infections often occur in rural areas lacking proper diagnostic infrastructure as exemplified by monkeypox, which is endemic in Western and Central Africa. While PCR detection requires dema...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Daniel, Pauly, Diana, Zydek, Martin, Miller, Lilija, Piesker, Janett, Laue, Michael, Lisdat, Fred, Dorner, Martin B., Dorner, Brigitte G., Nitsche, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773239/
https://www.ncbi.nlm.nih.gov/pubmed/26930499
http://dx.doi.org/10.1371/journal.pone.0150110
_version_ 1782418701560053760
author Stern, Daniel
Pauly, Diana
Zydek, Martin
Miller, Lilija
Piesker, Janett
Laue, Michael
Lisdat, Fred
Dorner, Martin B.
Dorner, Brigitte G.
Nitsche, Andreas
author_facet Stern, Daniel
Pauly, Diana
Zydek, Martin
Miller, Lilija
Piesker, Janett
Laue, Michael
Lisdat, Fred
Dorner, Martin B.
Dorner, Brigitte G.
Nitsche, Andreas
author_sort Stern, Daniel
collection PubMed
description Orthopoxvirus species like cowpox, vaccinia and monkeypox virus cause zoonotic infections in humans worldwide. Infections often occur in rural areas lacking proper diagnostic infrastructure as exemplified by monkeypox, which is endemic in Western and Central Africa. While PCR detection requires demanding equipment and is restricted to genome detection, the evidence of virus particles can complement or replace PCR. Therefore, an easily distributable and manageable antigen capture enzyme-linked immunosorbent assay (ELISA) for the detection of orthopoxviruses was developed to facilitate particle detection. By comparing the virus particle binding properties of polyclonal antibodies developed against surface-exposed attachment or fusion proteins, the surface protein A27 was found to be a well-bound, highly immunogenic and exposed target for antibodies aiming at virus particle detection. Subsequently, eight monoclonal anti-A27 antibodies were generated and characterized by peptide epitope mapping and surface plasmon resonance measurements. All antibodies were found to bind with high affinity to two epitopes at the heparin binding site of A27, toward either the N- or C-terminal of the crucial KKEP-segment of A27. Two antibodies recognizing different epitopes were implemented in an antigen capture ELISA. Validation showed robust detection of virus particles from 11 different orthopoxvirus isolates pathogenic to humans, with the exception of MVA, which is apathogenic to humans. Most orthopoxviruses could be detected reliably for viral loads above 1 × 10(3) PFU/mL. To our knowledge, this is the first solely monoclonal and therefore reproducible antibody-based antigen capture ELISA able to detect all human pathogenic orthopoxviruses including monkeypox virus, except variola virus which was not included. Therefore, the newly developed antibody-based assay represents important progress towards feasible particle detection of this important genus of viruses.
format Online
Article
Text
id pubmed-4773239
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47732392016-03-07 Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening Stern, Daniel Pauly, Diana Zydek, Martin Miller, Lilija Piesker, Janett Laue, Michael Lisdat, Fred Dorner, Martin B. Dorner, Brigitte G. Nitsche, Andreas PLoS One Research Article Orthopoxvirus species like cowpox, vaccinia and monkeypox virus cause zoonotic infections in humans worldwide. Infections often occur in rural areas lacking proper diagnostic infrastructure as exemplified by monkeypox, which is endemic in Western and Central Africa. While PCR detection requires demanding equipment and is restricted to genome detection, the evidence of virus particles can complement or replace PCR. Therefore, an easily distributable and manageable antigen capture enzyme-linked immunosorbent assay (ELISA) for the detection of orthopoxviruses was developed to facilitate particle detection. By comparing the virus particle binding properties of polyclonal antibodies developed against surface-exposed attachment or fusion proteins, the surface protein A27 was found to be a well-bound, highly immunogenic and exposed target for antibodies aiming at virus particle detection. Subsequently, eight monoclonal anti-A27 antibodies were generated and characterized by peptide epitope mapping and surface plasmon resonance measurements. All antibodies were found to bind with high affinity to two epitopes at the heparin binding site of A27, toward either the N- or C-terminal of the crucial KKEP-segment of A27. Two antibodies recognizing different epitopes were implemented in an antigen capture ELISA. Validation showed robust detection of virus particles from 11 different orthopoxvirus isolates pathogenic to humans, with the exception of MVA, which is apathogenic to humans. Most orthopoxviruses could be detected reliably for viral loads above 1 × 10(3) PFU/mL. To our knowledge, this is the first solely monoclonal and therefore reproducible antibody-based antigen capture ELISA able to detect all human pathogenic orthopoxviruses including monkeypox virus, except variola virus which was not included. Therefore, the newly developed antibody-based assay represents important progress towards feasible particle detection of this important genus of viruses. Public Library of Science 2016-03-01 /pmc/articles/PMC4773239/ /pubmed/26930499 http://dx.doi.org/10.1371/journal.pone.0150110 Text en © 2016 Stern et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Stern, Daniel
Pauly, Diana
Zydek, Martin
Miller, Lilija
Piesker, Janett
Laue, Michael
Lisdat, Fred
Dorner, Martin B.
Dorner, Brigitte G.
Nitsche, Andreas
Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title_full Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title_fullStr Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title_full_unstemmed Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title_short Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses – Target Selection and Optimized Screening
title_sort development of a genus-specific antigen capture elisa for orthopoxviruses – target selection and optimized screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773239/
https://www.ncbi.nlm.nih.gov/pubmed/26930499
http://dx.doi.org/10.1371/journal.pone.0150110
work_keys_str_mv AT sterndaniel developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT paulydiana developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT zydekmartin developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT millerlilija developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT pieskerjanett developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT lauemichael developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT lisdatfred developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT dornermartinb developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT dornerbrigitteg developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening
AT nitscheandreas developmentofagenusspecificantigencaptureelisafororthopoxvirusestargetselectionandoptimizedscreening